1.  Understand biologics' role in escalating health care expenditures in the U.S.

2.  Compare and contrast the features of the small molecule-generic and biologic-biosimilar relationships.

3.  Evaluate barriers to biosimilar market penetration and individual prescribing.

Session date: 
06/27/2019 - 8:00am to 9:00am CDT
Evanston, IL 60201
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Garth W. Strohbehn, M.D., M.Phil.